Algernon Pharmaceuticals Inc. AGNPD Stock
Algernon Pharmaceuticals Inc. Price Chart
Algernon Pharmaceuticals Inc. AGNPD Financial and Trading Overview
Algernon Pharmaceuticals Inc. stock price | 3.26 USD |
Previous Close | 3.45 USD |
Open | 3.15 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 3.15 - 3.55 USD |
52 Week Range | 2.5 - 32.5 USD |
Volume | 8.23K USD |
Avg. Volume | 5.26K USD |
Market Cap | 6.26M USD |
Beta (5Y Monthly) | 0.161103 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AGNPD Valuation Measures
Enterprise Value | 3.05M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.5990445 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Algernon Pharmaceuticals Inc. Stock Price History
Beta (5Y Monthly) | 0.161103 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 32.5 USD |
52 Week Low | 2.5 USD |
50-Day Moving Average | 4.19 USD |
200-Day Moving Average | 8.41 USD |
AGNPD Share Statistics
Avg. Volume (3 month) | 5.26K USD |
Avg. Daily Volume (10-Days) | 6.15K USD |
Shares Outstanding | 1.67M |
Float | 1.64M |
Short Ratio | N/A |
% Held by Insiders | 1.28% |
% Held by Institutions | 5.92% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | August 31, 2021 |
Most Recent Quarter (mrq) | August 31, 2021 |
Next Fiscal Year End | August 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -42.88% |
Return on Equity (ttm) | -72.51% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | -7734080 USD |
Diluted EPS (ttm) | -3.882 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.41M USD |
Total Cash Per Share (mrq) | 1.44 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 4.802 |
Book Value Per Share (mrq) | 5.442 |
Cash Flow Statement
Operating Cash Flow (ttm) | -7822617 USD |
Levered Free Cash Flow (ttm) | -4686715 USD |
Profile of Algernon Pharmaceuticals Inc.
Country | United States |
State | BC |
City | Vancouver |
Address | 700 West Pender Street |
ZIP | V6C 1G8 |
Phone | N/A |
Website | https://algernonpharmaceuticals.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of nonÂalcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188, a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Q&A For Algernon Pharmaceuticals Inc. Stock
What is a current AGNPD stock price?
Algernon Pharmaceuticals Inc. AGNPD stock price today per share is 3.26 USD.
How to purchase Algernon Pharmaceuticals Inc. stock?
You can buy AGNPD shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Algernon Pharmaceuticals Inc.?
The stock symbol or ticker of Algernon Pharmaceuticals Inc. is AGNPD.
Which industry does the Algernon Pharmaceuticals Inc. company belong to?
The Algernon Pharmaceuticals Inc. industry is Biotechnology.
How many shares does Algernon Pharmaceuticals Inc. have in circulation?
The max supply of Algernon Pharmaceuticals Inc. shares is 0.
What is Algernon Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
Algernon Pharmaceuticals Inc. PE Ratio is 0.00000000 now.
What was Algernon Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
Algernon Pharmaceuticals Inc. EPS is 0 USD over the trailing 12 months.
Which sector does the Algernon Pharmaceuticals Inc. company belong to?
The Algernon Pharmaceuticals Inc. sector is Healthcare.